Myasthenia gravis disclosed by lithium carbonate.
Alevizos
B
B
Gatzonis
S
S
Anagnostara
Ch
Ch
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D015673:Fatigue Syndrome, Chronic / Q000209:etiology; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis*; D011239:Prednisolone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D013934:Thymectomy
D000893:Anti-Inflammatory Agents; D018692:Antimanic Agents; D002800:Cholinesterase Inhibitors; D016651:Lithium Carbonate; D011239:Prednisolone; D011729:Pyridostigmine Bromide